Literature DB >> 3882230

Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide.

A B Gasser, W P Steward, J Wagstaff, J H Scarffe, D Crowther.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3882230

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Etoposide and cisplatinum in resistant lymphomas.

Authors:  N Tubiana; C Lejeune; N Horchowski; J A Gastaut; M Finaud; D Sainty; G Sebahoun; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen.

Authors:  N Gad-el-Mawla; M H Hussein; S Abdel-Hadi; O el-Taneer; M Adde; I Magrath
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.